Is the rise in drug stock prices sustainable?


Fine run: Pharmaniaga has risen by as much as 530% from its March-MCO low of 88 sen in the recent pharmaceutical stock play.

AFTER going through a sustained phase of accumulation, following the announcement of the movement control order (MCO), pharmaceutical stocks saw a sudden surge in prices during the week.

They have seen strong gains after traders and investors drove up their prices in expectations of a Covid-19 vaccine that would be available in the near future.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Pharmaniaga , Duopharma , MCO , Apex , Kotra Industries ,

   

Next In Business News

Decarbonising cement: Are we ready?
After a homeowner passes
A stinky nuisance: When septic tanks burst
Ringgit to trade in tight range of 4.46-4.48 versus US dollar next week
Building a firm facade
Portfolio positioning under Trump era
EQ expands to Thailand
RHB, CGC in LCTF portfolio guarantee deal
Market struggles to find direction
Sapura Energy ‘in a good place now’

Others Also Read